MEP12109A - Reconstituted surfactants having improved properties - Google Patents

Reconstituted surfactants having improved properties

Info

Publication number
MEP12109A
MEP12109A MEP-121/09A MEP12109A MEP12109A ME P12109 A MEP12109 A ME P12109A ME P12109 A MEP12109 A ME P12109A ME P12109 A MEP12109 A ME P12109A
Authority
ME
Montenegro
Prior art keywords
improved properties
reconstituted surfactants
surfactants
relates
present
Prior art date
Application number
MEP-121/09A
Other languages
Bosnian (bs)
English (en)
Inventor
Jan Johansson
Tore Curstedt
Bengt Robertson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP12109(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of MEP12109A publication Critical patent/MEP12109A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
MEP-121/09A 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties MEP12109A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06021521 2006-10-13
PCT/IB2007/002841 WO2008044109A1 (en) 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties

Publications (1)

Publication Number Publication Date
MEP12109A true MEP12109A (en) 2011-12-20

Family

ID=39079026

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-121/09A MEP12109A (en) 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties
MEP-2016-20A ME02326B (me) 2006-10-13 2007-09-28 Rekonstituisani surfaktanti sa poboljšanim svojstvima

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2016-20A ME02326B (me) 2006-10-13 2007-09-28 Rekonstituisani surfaktanti sa poboljšanim svojstvima

Country Status (35)

Country Link
US (2) US8183210B2 (da)
EP (1) EP2078038B1 (da)
JP (2) JP5405307B2 (da)
KR (1) KR101328851B1 (da)
CN (2) CN103169947B (da)
AR (2) AR063263A1 (da)
AU (1) AU2007306075B2 (da)
BR (1) BRPI0715317B1 (da)
CA (1) CA2666344C (da)
CL (1) CL2007002931A1 (da)
CO (1) CO6400235A2 (da)
CY (1) CY1114716T1 (da)
DK (1) DK2078038T3 (da)
EA (1) EA015802B1 (da)
ES (1) ES2438727T3 (da)
GE (1) GEP20125531B (da)
HR (1) HRP20140052T1 (da)
IL (1) IL198075A (da)
JO (1) JO2963B1 (da)
MA (1) MA31062B1 (da)
ME (2) MEP12109A (da)
MX (1) MX343064B (da)
MY (1) MY148127A (da)
NO (1) NO342038B1 (da)
NZ (1) NZ576189A (da)
PE (1) PE20081184A1 (da)
PL (1) PL2078038T3 (da)
PT (1) PT2078038E (da)
RS (1) RS53172B (da)
SI (1) SI2078038T1 (da)
TN (1) TN2009000099A1 (da)
TW (1) TWI388333B (da)
UA (1) UA94477C2 (da)
WO (1) WO2008044109A1 (da)
ZA (1) ZA200902481B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008011559A2 (en) 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) * 2010-09-02 2012-12-05 华东理工大学 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
WO2013120058A2 (en) * 2012-02-09 2013-08-15 University Of Rochester Novel sp-b & sp-c peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en) 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
US9074018B2 (en) 2012-11-21 2015-07-07 Chiesi Farmaceutici S.P.A. Reconstituted pulmonary surfactants
EP3393489B1 (en) 2015-12-17 2021-09-01 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Synthetic lung surfactant with enhanced stability and effectiveness
CA3016810C (en) 2016-03-07 2024-04-02 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for administering ppar.gamma. agonists, surfactant peptides and phospholipids
BR112019003673A2 (pt) 2016-08-24 2019-05-21 Chiesi Farmaceutici S.P.A. formulação farmacêutica, uso de uma formulação farmacêutica e método para evitar o aumento da viscosidade durante o armazenamento de uma formulação farmacêutica
US12606609B2 (en) 2020-01-28 2026-04-21 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
WO2022082082A2 (en) * 2020-10-16 2022-04-21 Sherwood Russ Lehrman Lung treatment compositions
WO2025024609A1 (en) * 2023-07-25 2025-01-30 Biosuperior Technology, Inc. Polypeptides for lung surfactant compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08512056A (ja) * 1993-06-30 1996-12-17 ジェネンテク・インコーポレイテッド リポソームの製造法
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) * 1999-11-23 2006-06-20 Gofigure, L.L.C. System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
WO2008011559A2 (en) * 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides

Also Published As

Publication number Publication date
JP5405307B2 (ja) 2014-02-05
ES2438727T3 (es) 2014-01-20
US8183210B2 (en) 2012-05-22
WO2008044109A1 (en) 2008-04-17
CN103169947B (zh) 2014-10-29
CO6400235A2 (es) 2012-03-15
MY148127A (en) 2013-02-28
JP2010505937A (ja) 2010-02-25
JO2963B1 (en) 2016-03-15
UA94477C2 (ru) 2011-05-10
RS53172B (sr) 2014-06-30
CN103169947A (zh) 2013-06-26
BRPI0715317A2 (pt) 2013-07-09
MX2009003638A (es) 2009-04-22
EP2078038A1 (en) 2009-07-15
US20130079275A1 (en) 2013-03-28
KR101328851B1 (ko) 2013-11-14
CY1114716T1 (el) 2016-10-05
HK1185274A1 (en) 2014-02-14
CL2007002931A1 (es) 2008-03-24
IL198075A0 (en) 2011-08-01
AU2007306075A1 (en) 2008-04-17
HK1134497A1 (en) 2010-04-30
NO342038B1 (no) 2018-03-19
TW200824705A (en) 2008-06-16
KR20090083892A (ko) 2009-08-04
NZ576189A (en) 2011-09-30
GEP20125531B (en) 2012-05-25
IL198075A (en) 2016-04-21
DK2078038T3 (da) 2013-12-02
MA31062B1 (fr) 2010-01-04
MX343064B (es) 2016-10-24
ME02326B (me) 2016-06-20
CA2666344C (en) 2017-04-18
SI2078038T1 (sl) 2014-02-28
US20100004173A1 (en) 2010-01-07
TN2009000099A1 (en) 2010-08-19
PL2078038T3 (pl) 2014-05-30
CA2666344A1 (en) 2008-04-17
TWI388333B (zh) 2013-03-11
BRPI0715317B1 (pt) 2021-10-05
PT2078038E (pt) 2013-12-12
HRP20140052T1 (hr) 2014-02-28
EA200900373A1 (ru) 2009-10-30
AR063263A1 (es) 2009-01-14
CN101522711A (zh) 2009-09-02
US9238058B2 (en) 2016-01-19
JP2013241449A (ja) 2013-12-05
CN101522711B (zh) 2013-11-13
NO20091441L (no) 2009-06-23
AR113422A2 (es) 2020-04-29
EA015802B1 (ru) 2011-12-30
EP2078038B1 (en) 2013-11-20
PE20081184A1 (es) 2008-09-26
ZA200902481B (en) 2010-07-28
AU2007306075B2 (en) 2012-08-09

Similar Documents

Publication Publication Date Title
EA200900373A1 (ru) Реконструированные сурфактанты, обладающие улучшенными свойствами
ATE544461T1 (de) Rekonstituierte tenside mit verbesserten eigenschaften
BRPI1010120A2 (pt) composição de surfactante reconstituído melhorada contendo análogos de proteína b do surfactante (sp-b) e proteína c do surfactante ( sp-c)
PE20110023A1 (es) Composiciones inmunogenicas de antigenos de staphylococcus aureus
MX340541B (es) Secuencias de aminoacidos mejoradas dirigidas contra virus sincitial respiratorio humano y polipeptidos que comprenden las mismas para la prevencion y/o tratamiento de infecciones del tracto respiratorio.
WO2008011559A3 (en) Synthetic lung surfactant and use thereof
AR108631A1 (es) Formulación de neurotoxinas
ECSP10010516A (es) Uso de variantes de igf-i pegiladas para el tratamiento de trastornos neuromusculares
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
PL1940381T3 (pl) Farmaceutyczne kompozycje do oczu oparte na aminokwasach i hialuronianie sodu
WO2013120058A3 (en) Novel sp-b & sp-c peptides, synthetic lung surfactants, and use thereof
MX2022004944A (es) Composiciones y metodos para minimizar la perdida de proteinas a concentraciones de proteinas bajas.
BRPI0813619A2 (pt) peptídeos surfactantes pulmonares sintéticos
BRPI0707420A8 (pt) composições contendo peptídeos com aminoácidos e métodos não naturais do uso
DE602005019416D1 (de) Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid
DE602006020155D1 (de) Pharmazeutische wundheilungs-zusammensetzungen in ren und natriumhyaluronat
TW200732002A (en) Lens care compositions having a persistent cleaning efficacy
MX2009002717A (es) Composiciones y metodos para tratamiento del sindrome de fatiga cronica y enfermedades neurodegenerativas.
NZ741483A (en) Antibody and protein formulations
UA96003C2 (en) PHARMACEUTICAL COMPOSITION [Aib8,35]hGLP-1(7-36)NH2